On January 13, 2021, SFARI will host a virtual Social focused on the Bridge to Independence (BTI) Award, in conjunction with the SfN Global Connectome: A Virtual Event.
On January 11, 2021, SFARI will host a virtual Social in conjunction with the SfN Global Connectome: A Virtual Event.
Evan Eichler discussed his research on the genetics of autism and related neurodevelopmental conditions.
Emmanuel Mignot discussed sleep biology as well as sleep disorders and their impact. He presented a link to what is known on the genetics of sleep and sleep disorders. He emphasized the need for large scale objective sleep recording studies with genomic and proteomic analysis to better understand the molecular pathways regulating sleep and circadian biology.
From parent advocate to nonprofit chief science officer, to biotherapeutic company cofounder — A personal journey through drug development for Angelman syndrome
Allyson Berent discussed the journey that led her to becoming chief science officer of the largest research funding foundation for Angelman syndrome in the world (Foundation for Angelman Syndrome Therapeutics [FAST]), and the cofounder and chief operating officer of GeneTx Biotherapeutics — a biotech company solely focused on developing an antisense oligonucleotide for the treatment of Angelman syndrome — after her daughter was diagnosed with Angelman syndrome at 5.5 months old.
Associate Professor in Medicine, Harvard Medical School
Associated Researcher, Broad Institute
Benjamin Neale discussed progress in mapping genetic risk factors for autism, schizophrenia and bipolar disorder.